Among the plethora of pathophysiological changes in sepsis, the enhanced activity of the stress responsive enzyme sphingomyelin-phosphodiesterase 1 (SMPD1) might function as a promising target for therapeutic interventions11–13. The gene discussed is SMPD1; the disease is Sepsis.